Lp(a) is the latest in a series of “bad” “cholesterol” that is believed to cause heart disease. They tested a drug that lowered Lp(a), but had little effect on heart disease:
It’s the problem that occurs with LDL (another “bad” “cholesterol”) and ApoB (yet another bad cholesterol), where many people with high versions of these do not have heart disease. There are drugs (like statins) that lower LDL, but some believe statins work not by lowering LDL but through other mechanisms (such as increasing nitric oxide and/or improving endothelial health).
There are other Lp(a) drugs in the pipeline, but if there is a drug that reduces Lp(a) by 80% yet doesn’t help with heart disease, if those other drugs work, that means to me that they don’t work by lowering Lp(a).

